Peregrine Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Peregrine Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$4.91M	Sell
2024 Q3	$6.23M	Sell
2024 Q2	$5.41M	Sell
2024 Q1	$6.92M	Buy